Vaccines and treatments are in trials, but the virus remains a leading killer of infants worldwide.
Source: New York Times
Scientists Are Gaining On RSV, a Persistent Threat to Children
Published in Babies and Infants, Children and Childhood, GlaxoSmithKline PLC, Infant Mortality, Pfizer Inc, Respiratory Diseases, Respiratory Syncytial Virus (RSV), Vaccination and Immunization and your-feed-science
More from Babies and InfantsMore posts in Babies and Infants »
More from Children and ChildhoodMore posts in Children and Childhood »
More from GlaxoSmithKline PLCMore posts in GlaxoSmithKline PLC »
More from Infant MortalityMore posts in Infant Mortality »
More from Pfizer IncMore posts in Pfizer Inc »
- Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.
- N.Y.C. to Offer Paxlovid at Mobile Virus Test Sites, First in U.S.
- Vaccines for Young Children Are Coming, but Many Parents Have Tough Questions
- A Better Way to Measure Immunity in Children
- Mounting Data Shows J&J Vaccine as Effective as Pfizer and Moderna
More from Respiratory DiseasesMore posts in Respiratory Diseases »
More from Respiratory Syncytial Virus (RSV)More posts in Respiratory Syncytial Virus (RSV) »
More from Vaccination and ImmunizationMore posts in Vaccination and Immunization »
More from your-feed-scienceMore posts in your-feed-science »
- Covid May Spread From Corpses, Scientists Report
- Grant Wahl Died of a Burst Blood Vessel, His Family Says
- Long Covid Has Played Role in More Than 3,500 Deaths in US, CDC Says
- Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.
- As the Pandemic Drags On, Americans Struggle for New Balance
Be First to Comment